Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug

Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug

US Patent 8394791 · Granted Mar 12, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CCR2 receptor antagonists and uses thereof2025
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R2024
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2023
Crystalline salts of a B-RAF kinase inhibitor2023
CCR2 receptor antagonists and uses thereof2023
Crystalline salts of a B-RAF kinase inhibitor2022
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R2021
Process for the manufacture of 6-alkynyl-pyridine derivatives2021
CCR2 receptor antagonists and uses thereof2021
Medical use of compound III2021
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD an2020
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R2020